AI Therapeutics Logo.jpg
AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant
18 août 2023 10h37 HE | AI Therapeutics, Inc.
GUILFORD, Conn., Aug. 18, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement...
Logo.png
Lung Transplant Rejection Pipeline Analysis | Clinical Trials Evaluation Research Report 2022 by DelveInsight
31 mars 2022 13h00 HE | DelveInsight Business Research LLP
Las Vegas, USA, March 31, 2022 (GLOBE NEWSWIRE) -- Lung Transplant Rejection Pipeline Analysis | Clinical Trials Evaluation Research Report 2022 by DelveInsight  As the number of lung...
22157.jpg
Global Obstructive Lung Disease Management Markets 2021: Opportunities Led by Big Pharma and Medical Device Companies and New Collaborations in Developing Affordable and Quality-Driven Treatments
23 sept. 2021 04h58 HE | Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Obstructive Lung Disease Management Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report provides a...
22157.jpg
Global Idiopathic Pulmonary Fibrosis Disease Treatment Markets, 2018-2019 & 2020-2024
08 sept. 2021 03h58 HE | Research and Markets
Dublin, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets" report has been added to ResearchAndMarkets.com's offering.The current report...
Oklahoma Firefighter and Father-of-Four Survives COVID-19 and Receives Lifesaving Lung Transplant at Dignity Health St. Joseph’s in Phoenix PHOENIX, April 09, 2021 (GLOBE NEWSWIRE) -- A 44-year-old firefighter and father-of-four from Oklahoma recently received a lifesaving double lung transplant at Norton Thoracic Institute at Dignity...
Infectious Diseases
Infectious Diseases a Hot Topic at the International Society for Heart and Lung Transplantation 38th Annual Meeting and Scientific Sessions NICE, FR, April 13, 2018 (GLOBE NEWSWIRE) -- During Oral Session 38 at the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions, two studies...
Technology and Pathw
Technology and Pathways Advancing Future Transplant Patient Care Discussed at the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions NICE, FR, April 13, 2018 (GLOBE NEWSWIRE) -- During the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions, an entire symposium was...
GREAT DEBATES IN PUL
GREAT DEBATES IN PULMONARY HYPERTENSION AT THE 37th ANNUAL ISHLT MEETING AND SCIENTIFIC SESSIONS San Diego, April 07, 2017 (GLOBE NEWSWIRE) -- Today at the 37th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions, researchers and physicians...
TWO STUDIES PRESENTED AT THE 37TH ANNUAL ISHLT MEETING & SCIENTIFIC SESSIONS REVEAL EARLY MORTALITY IN LUNG TRANSPLANT RECIPIENTS AND RELATED OUTCOMES IN THE MOMENTUM 3 TRIAL San Diego, April 06, 2017 (GLOBE NEWSWIRE) -- Today at the 37th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions, researchers shared results...
Michael-Weyant_DoubleLungLiverTransplant_035 (1)
University of Colorado Hospital Announces new Center for Lungs and Breathing
01 oct. 2015 09h05 HE | UCHealth
AURORA, COLO., Oct. 1, 2015 (GLOBE NEWSWIRE) -- UCHealth's University of Colorado Hospital (UCH), a national leader in pulmonology, cancer and upper airway disorders, opens its new multidisciplinary...